tiprankstipranks
Apollomics announces changes in executive leadership team
PremiumThe FlyApollomics announces changes in executive leadership team
5M ago
Apollomics announces vebreltinib data at the 2024 ASCO meeting
Premium
The Fly
Apollomics announces vebreltinib data at the 2024 ASCO meeting
6M ago
Apollomics price target lowered to $2 from $5 at H.C. Wainwright
Premium
The Fly
Apollomics price target lowered to $2 from $5 at H.C. Wainwright
7M ago
Apollomics appoints Plunkett as CFO
PremiumThe FlyApollomics appoints Plunkett as CFO
9M ago
Apollomics receives Nasdaq notification regarding minimum bid price
Premium
The Fly
Apollomics receives Nasdaq notification regarding minimum bid price
10M ago
Apollomics completes enrollment in Phase 3 bridging study of APL-106
Premium
The Fly
Apollomics completes enrollment in Phase 3 bridging study of APL-106
11M ago
Apollomics announces report of vebreltinib activity in GBM with PTPRZ-MET fusion
PremiumThe FlyApollomics announces report of vebreltinib activity in GBM with PTPRZ-MET fusion
1y ago
Apollomics announces efficacy of vebreltinib in NSCLC patients
Premium
The Fly
Apollomics announces efficacy of vebreltinib in NSCLC patients
1y ago
Apollomics price target lowered to $17 from $18 at H.C. Wainwright
Premium
The Fly
Apollomics price target lowered to $17 from $18 at H.C. Wainwright
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100